TREATMENT OF SPORADIC GOITER WITH THYROXINE

被引：15

作者：

EDMONDS, C

机构：

[1] Northwick Park Hospital and Clinical Research Centre, Harrow, HA1 3UJ, Watford Road

来源：

CLINICAL ENDOCRINOLOGY | 1992年 / 36卷 / 01期

关键词：

D O I：

10.1111/j.1365-2265.1992.tb02897.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：21 / 23

页数：3

共 24 条

[1] THE LONG-TERM OUTCOME OF THYROIDECTOMY FOR SPORADIC NON-TOXIC GOITER
BERGHOUT, A
WIERSINGA, WM
DREXHAGE, HA
VANTROTSENBURG, P
SMITS, NJ
VANDERGAAG, RD
TOUBER, JL
[J]. CLINICAL ENDOCRINOLOGY, 1989, 31 (02) : 193 - 199
[2] COMPARISON OF PLACEBO WITH L-THYROXINE ALONE OR WITH CARBIMAZOLE FOR TREATMENT OF SPORADIC NONTOXIC GOITER
BERGHOUT, A
WIERSINGA, WM
DREXHAGE, HA
SMITS, NJ
TOUBER, JL
[J]. LANCET, 1990, 336 (8709) : 193 - 197
[3] CAN SERUM THYROGLOBULIN PREDICT THE EFFECT OF THYROID-HORMONE THERAPY ON GOITER GROWTH
BURGI, U
SCAZZIGA, BR
ROSSELET, PO
BURGI, H
STUDER, H
[J]. ACTA ENDOCRINOLOGICA, 1988, 119 (01): : 118 - 124
[4] RELATIONSHIP BETWEEN SERUM THYROTROPIN LEVEL, PREVALENCE OF GOITER AND PATTERN OF IODINE METABOLISM IN IDJWI ISLAND
DELANGE, F
HERSHMAN, JM
ERMANS, AM
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1971, 33 (02) : 261 - +
[5] DREXHAGE HA, 1980, LANCET, V2, P287
[6] RECURRENCE OF NONTOXIC GOITER WITH AND WITHOUT POSTOPERATIVE THYROXINE MEDICATION
GEERDSEN, JP
FROLUND, L
[J]. CLINICAL ENDOCRINOLOGY, 1984, 21 (05) : 529 - 533
[7] SUPPRESSIVE THERAPY WITH LEVOTHYROXINE FOR SOLITARY THYROID-NODULES - A DOUBLE-BLIND CONTROLLED CLINICAL-STUDY
GHARIB, H
JAMES, EM
CHARBONEAU, JW
NAESSENS, JM
OFFORD, KP
GORMAN, CA
[J]. NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (02) : 70 - 75
[8] TREATMENT OF SIMPLE GOITER WITH THYROID
GREER, MA
ASTWOOD, EB
[J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1953, 13 (11) : 1312 - 1331
[9] DOES PROPHYLACTIC THYROXINE TREATMENT AFTER OPERATION FOR NONTOXIC GOITER INFLUENCE THYROID SIZE
HEGEDUS, L
HANSEN, JM
VEIERGANG, D
KARSTRUP, S
[J]. BRITISH MEDICAL JOURNAL, 1987, 294 (6575) : 801 - 803
[10] INFLUENCE OF THYROXINE TREATMENT ON THYROID SIZE AND ANTITHYROID PEROXIDASE ANTIBODIES IN HASHIMOTO THYROIDITIS
HEGEDUS, L
HANSEN, JM
FELDTRASMUSSEN, U
HANSEN, BM
HOIERMADSEN, M
[J]. CLINICAL ENDOCRINOLOGY, 1991, 35 (03) : 235 - 238

← 1 2 3 →